CHC Healthcare Group (4164.TW)
TWD 40.15
(-1.83%)
TWD 40.15
(-1.83%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | 962.58 Million | 656.65 Million | 692.79 Million | 915.46 Million | 1.18 Billion | 390.68 Million |
| Net Income | 559.43 Million | 483.83 Million | 491.06 Million | 463.99 Million | 476.59 Million | 368.16 Million |
| Depreciation & Amortization | 594.46 Million | 499.38 Million | 460.59 Million | 440.34 Million | 411.75 Million | 428.59 Million |
| Deferred income taxes | -186.81 Million | - | -186.59 Million | -163.77 Million | -172.33 Million | -140.7 Million |
| Stock-based compensation | 286 Thousand | 1.75 Million | 3.2 Million | 4.46 Million | 5.72 Million | 3.23 Million |
| Change in working capital | -97.76 Million | -211.15 Million | -131.16 Million | 100.34 Million | 395.45 Million | -349.02 Million |
| Other non-cash items | 92.99 Million | -117.16 Million | 55.68 Million | 70.09 Million | 72.5 Million | 80.41 Million |
| Investing Cash Flow | -500.46 Million | -339.97 Million | -990.35 Million | -731.06 Million | -646.95 Million | -406.2 Million |
| Investments in PPE | -575.67 Million | -682.63 Million | -514.09 Million | -721.26 Million | -344.3 Million | -362.47 Million |
| Acquisitions | -49.52 Million | 1.23 Million | -315.02 Million | 8.83 Million | 7.77 Million | -8.94 Million |
| Investment purchases | -54.32 Million | -2.07 Million | -74.11 Million | -8.12 Million | -238.97 Million | -68.96 Million |
| Sales/Maturities of investments | 143.64 Million | 133.09 Million | 51.97 Million | 60.56 Million | -50.09 Million | 58 Million |
| Other Investing Activities | 35.4 Million | 210.39 Million | -139.09 Million | -71.07 Million | -21.34 Million | -23.82 Million |
| Financing Cash Flow | -42.04 Million | -346.45 Million | 415.05 Million | -51.31 Million | -506.01 Million | -187.96 Million |
| Debt repayment | -2.32 Billion | -262.96 Million | -3.4 Billion | -5.39 Billion | -5.04 Billion | -5.19 Billion |
| Dividends payments | -324.72 Million | -323.87 Million | -313.64 Million | -281.26 Million | -250.04 Million | -153.9 Million |
| Common Stock Repurchased | 2.58 Billion | - | 4.01 Billion | 5.62 Billion | 4.75 Billion | -34.95 Million |
| Common Stock Issuance | 18.36 Million | 14.36 Million | 174.47 Million | 8.24 Million | 33.24 Million | 5.07 Billion |
| Other Financing Activities | 7.37 Million | -285.53 Million | -54.84 Million | -9.6 Million | 1.58 Million | 125.15 Million |
| Accounts receivables | -120.54 Million | -158.85 Million | 80.97 Million | 77.33 Million | -77.86 Million | -72.71 Million |
| Accounts payables | 48.7 Million | 128.55 Million | 26.77 Million | -68 Million | 8.97 Million | 83.94 Million |
| Inventory | -76.68 Million | -209.22 Million | 7.15 Million | 121.27 Million | -26.11 Million | -182.45 Million |
| Other working capital | 50.76 Million | 28.37 Million | -246.06 Million | -30.25 Million | 490.45 Million | -166.57 Million |
| Cash at beginning of period | 1.47 Billion | 1.49 Billion | 1.38 Billion | 1.24 Billion | 1.2 Billion | 1.44 Billion |
| Cash at end of period | 1.89 Billion | 1.47 Billion | 1.49 Billion | 1.38 Billion | 1.24 Billion | 1.2 Billion |
| Capital Expenditure | -575.67 Million | -682.63 Million | -514.09 Million | -721.26 Million | -344.3 Million | -362.47 Million |
| Effect of forex changes on cash | -1.54 Million | 8.69 Million | -4.09 Million | 2.2 Million | -1.12 Million | -31.24 Million |
| Net cash flow / Change in cash | 418.53 Million | -21.07 Million | 113.4 Million | 135.28 Million | 35.59 Million | -234.72 Million |
| Free Cash Flow | 386.91 Million | -25.97 Million | 178.7 Million | 194.2 Million | 845.38 Million | 28.21 Million |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 28.16 Million | 13.57 Million | 559.43 Million | 257.87 Million | 60.38 Million | 131.96 Million |
| Depreciation & Amortization | 157.3 Million | 152.29 Million | 594.46 Million | 150.95 Million | 149.5 Million | 148.13 Million |
| Deferred income taxes | - | - | -186.81 Million | - | - | - |
| Stock-based compensation | - | - | 286 Thousand | - | - | - |
| Change in working capital | -287.24 Million | -57.18 Million | -97.76 Million | 274.37 Million | 41.37 Million | 1.58 Million |
| Other non-cash items | 503.74 Million | 24.59 Million | 92.99 Million | 521 Thousand | -22 Million | -73.72 Million |
| Investing Cash Flow | -40.93 Million | -200.72 Million | -500.46 Million | -62.02 Million | -190.82 Million | -110.42 Million |
| Investments in PPE | -73.47 Million | -186.26 Million | -575.67 Million | -84.32 Million | -138.23 Million | -242.97 Million |
| Acquisitions | 67.99 Million | -4.7 Million | -49.52 Million | 1.06 Million | 1.08 Million | 26.37 Million |
| Investment purchases | -25.25 Million | -1.64 Million | -54.32 Million | -1.19 Million | -1.08 Million | -26.37 Million |
| Sales/Maturities of investments | -1.31 Million | 2.55 Million | 143.64 Million | 25.17 Million | -1.25 Million | 19.06 Million |
| Other Investing Activities | -8.88 Million | -10.67 Million | 35.4 Million | -2.75 Million | -51.33 Million | 113.48 Million |
| Financing Cash Flow | -182.64 Million | 227.95 Million | -42.04 Million | -10.39 Million | -208.9 Million | -180.12 Million |
| Debt repayment | -162.69 Million | -222.33 Million | -2.32 Billion | -739.71 Million | -499.7 Million | -471.06 Million |
| Dividends payments | - | - | -324.72 Million | - | -324.72 Million | - |
| Common Stock Repurchased | - | - | 2.58 Billion | - | 324.72 Million | - |
| Common Stock Issuance | - | 266 Thousand | 18.36 Million | 231 Thousand | 1.92 Million | 13.57 Million |
| Other Financing Activities | -9.81 Million | 15.09 Million | 7.37 Million | 729.08 Million | 288.87 Million | 277.37 Million |
| Accounts receivables | -268.19 Million | 167.2 Million | -120.54 Million | -129.12 Million | 126.75 Million | -62.01 Million |
| Accounts payables | 2.42 Million | -58.02 Million | 48.7 Million | -15.66 Million | 40.58 Million | 144.31 Million |
| Inventory | -7.22 Million | -57.37 Million | -76.68 Million | 303.55 Million | -119.4 Million | -98.91 Million |
| Other working capital | -14.24 Million | -95.5 Million | 50.76 Million | 115.6 Million | -6.56 Million | 18.2 Million |
| Cash at beginning of period | 2.03 Billion | 1.89 Billion | 1.47 Billion | 1.28 Billion | 1.44 Billion | 1.53 Billion |
| Cash at end of period | 1.63 Billion | 2.03 Billion | 1.89 Billion | 1.89 Billion | 1.28 Billion | 1.44 Billion |
| Capital Expenditure | -73.47 Million | -186.26 Million | -575.67 Million | -84.32 Million | -138.23 Million | -242.97 Million |
| Effect of forex changes on cash | -806 Thousand | 3.59 Million | -1.54 Million | -4 Million | 6.1 Million | -3.98 Million |
| Net cash flow / Change in cash | -396.14 Million | 142.16 Million | 418.53 Million | 607.3 Million | -164.36 Million | -86.56 Million |
| Free Cash Flow | -259.11 Million | -74.92 Million | 386.91 Million | 599.4 Million | 91.02 Million | -35 Million |
SYF
7906
ONDO
ECRO
PRL
1561